Loxo Oncology

NCT06215430

Collaborator, Phase 1, Completed, 2021, 16 people, 22 Jan 2024, clinicaltrials.gov

NCT06181084

Collaborator, Phase 1, Completed, 2021, 60 people, 26 Dec 2023, clinicaltrials.gov

NCT06111521

Collaborator, Phase 1, Completed, 2023, 35 people, 1 Nov 2023, clinicaltrials.gov

NCT06043674

Collaborator, Phase 2, Recruiting, 2024, 70 people, 21 Sept 2023, clinicaltrials.gov

NCT05536349

Collaborator, Phase 2, Recruiting, 2022, 60 people, 10 Sept 2022, clinicaltrials.gov

NCT05529069

Collaborator, Phase 2, Recruiting, 2023, 30 people, 6 Sept 2022, clinicaltrials.gov

NCT05254743

Phase 3, Recruiting, 2022, 737 people, 24 Feb 2022, clinicaltrials.gov

NCT05176314

Phase 1, Completed, 2022, 32 people, 4 Jan 2022, clinicaltrials.gov

NCT04965493

Phase 3, Active, not recruiting, 2021, 600 people, 16 Jul 2021, clinicaltrials.gov

NCT04662255

Phase 3, Active, not recruiting, 2021, 500 people, 10 Dec 2020, clinicaltrials.gov

NCT04194944

Collaborator, Phase 3, Active, not recruiting, 2020, 261 people, 11 Dec 2019, clinicaltrials.gov

NCT03740529

Phase 1/2, Completed, 2019, 803 people, 14 Nov 2018, clinicaltrials.gov